UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007986 |
|---|---|
| Receipt number | R000008845 |
| Scientific Title | A Phase II study of Pemetrexed plus split Cisplatin followed by maintenance Pemetrexed in previously untreated patients with stage III/IV or recurrent post-operative non-small-cell with non-squamous lung cancer. OSAKA-LCSG1103 |
| Date of disclosure of the study information | 2012/05/18 |
| Last modified on | 2019/11/26 15:26:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/05/18 18:31:43 | ||
| 2 | Update | 2015/11/18 14:51:42 | Last name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Address TEL |
|
| 3 | Update | 2016/05/18 14:40:46 | Name of primary person or sponsor Institute Department Organization Organization Division |
|
| 4 | Update | 2019/11/26 15:06:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Nationality of Funding Organization Nationality of Funding Organization Organization Organization Address Address Tel |
|
| 5 | Update | 2019/11/26 15:15:58 | Date of IRB Last follow-up date Date of closure to data entry |
|
| 6 | Update | 2019/11/26 15:24:16 | Recruitment status |
|
| 7 | Update | 2019/11/26 15:26:59 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
